Loading company…
T2 Biosystems develops diagnostic systems for detecting pathogens, including bloodstream infections.
T2 Biosystems develops and commercializes diagnostic systems designed to detect pathogens quickly, with a focus on bloodstream infections. Its technology serves hospitals and laboratories. Founded in 2006 and based in Lexington, US, the company reported USD 7.19 mn in revenue and USD -48.81 mn in EBITDA in 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in